University of Chicago at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Chicago brings 1 presentation to ASH 2026 in New Orleans. Its program centres on lymphoma, especially bringing CAR T and other novel therapies into everyday care and answering community oncologists' questions. It also reflects on a year of program signaling for training program directors.
| Organization | ASH 2026 Attendance |
|---|---|
University of Chicago Chicago, IL | |
Private research university in Chicago with an academic medical center. | Symposium Fri Dec 11 7:00pm–10:00pm Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know: A CME-Accredited Friday Satellite Symposium Preceding the 68th ASH Annual Meeting Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research. Symposium Fri Dec 11 11:00am–2:00pm CAR T-Cell Agent Integration in Lymphoma: A Masterclass for Real-World Implementation CAR-T for relapsed B-cell lymphomas, from patient selection and referral to managing immune and nerve toxicities, survivorship, and off-the-shelf products. Symposium Fri Dec 11 3:00pm–6:00pm Evidence at Every Step: Applying the Latest CAR T-Cell Data Across the NHL Care Continuum Getting relapsed lymphoma patients to CAR-T sooner, with earlier referral, bridging therapy, sequencing choices, and management of immune and nerve toxicities. |
Instantly find 20 buyers from University of Chicago
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction